Arthritis patients resort to an inconvenient Medicare workaround to avoid pricey drugs
As many as 40,000 chronically ill seniors are choosing to endure uncomfortable, time-consuming intravenous infusions…
Category: Medicine
ALS patient lived with a brain-computer interface for 7 years. Here’s what researchers learned
Brain-computer interfaces are still years, and several FDA approvals, away from being available on the…
STAT+: Gilead wins U.S. approval for drug to treat autoimmune liver disease
The Food and Drug Administration on Wednesday approved a new treatment for primary biliary cholangitis,…
WHO declares mpox outbreak a global health emergency
The World Health Organization on Wednesday declared the spread of mpox in multiple African countries…
STAT+: Eli Lilly’s billions: Can the world’s most valuable pharma company keep inventing drugs at this pace?
On Tuesday, Eli Lilly unveiled a towering 346,000-square-foot laboratory in Boston’s Seaport District, a building…
Abortion, shingles, extreme heat, and sudden cardiac arrest
Want to stay on top of health news? Sign up to get our Morning Rounds newsletter in…
STAT+: Pharmalittle: We’re reading about an AstraZeneca U.K. vaccine plant, Medicare premiums, and more
Hello, everyone, and how are you today? We are doing just fine, thank you, especially…
Syros shares battered after it stops leukemia trial
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Opinion: Ultra-processed foods: the tobacco of the 21st century?
At the start of the clinic where I see patients with colorectal, stomach, pancreatic, and…
Opinion: Better safety studies could restore America’s confidence in vaccines
In February 2021, I received my second Covid-19 shot — the newly developed vaccine that…
STAT+: Grail announces layoffs as it looks to push forward blood-based cancer detection test
Cancer detection firm Grail announced sizable workforce cuts on Tuesday in a bid to save…
Illumina lays out plan to boost growth by helping scientists interpret sequencing data
SAN DIEGO — The unwinding of Illumina’s ill-fated acquisition of Grail earlier this year left…
STAT+: Acelyrin announces layoffs, strategy shift after late-stage trial results for anti-inflammatory drug
Acelyrin, a California biotech focused on immunology and inflammatory disease, announced Tuesday that its experimental…
The politics of mifepristone in the 2024 election
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
Morning Rounds: The billionaire who wants you angry about the food supply
Want to stay on top of health news? Sign up to get our Morning Rounds newsletter in…
.jpg)
STAT+: Pharmalittle: We’re reading about Novartis losing bid to block a generic, pharma deals, and more
Rise and shine, everyone, another busy day is on the way. Our mascots, for instance,…
STAT+: Otsuka starts selling depression digital therapeutic, expects to lose money on it
Otsuka Pharmaceutical has started selling Rejoyn, its Food and Drug Administration cleared prescription app that…
Atai advances oral psychedelic in depression
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Opinion: Aspirin after a broken bone: health equity in a $5 bottle
There are few things more exciting for researchers than to mount and complete a clinical…
STAT+: Meet the billionaire media mogul who’s taking on the food industry
WASHINGTON — The idea for Todd Wagner’s new advocacy organization FoodFight USA, he says, came…
STAT+: Why U.S. health care cybersecurity laws are better at protecting a corpse’s privacy than patients’ lives
Two days into a cyberattack on his hospital system, Nate Couture reached the end of…
Morning Rounds: Getting healthier in the checkout aisle and the alcohol aisle
Want to stay on top of health news? Sign up to get our Morning Rounds newsletter in…
STAT+: Pharmalittle: We’re reading about FDA rejecting MDMA; a nasal spray for allergic reactions, and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
A tough week for MDMA-assisted psychotherapy
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Opinion: Some ‘inconvenient’ truths about pharmacy benefit managers
Pharmacy benefit managers have been in the crosshairs of late, as the focus of media…
What’s in a drink? U.S. regulators consider new alcohol label, but health advocates want even more
If you twirl a bottle of alcohol and squint, you might see a text box…
Three MDMA therapy papers retracted over data integrity concerns
The journal Psychopharmacology has retracted three papers about MDMA-assisted psychotherapy — right on the heels…
Opinion: Getting to ‘Plan B’ for psychedelic medicine: Lessons from reproductive health
The Food and Drug Administration’s decision not to approve Lykos Therapeutics’ application for MDMA (a…
Opinion: Controlling obesity is a noble goal. Controlling mpox is a far more urgent one
As a global health investor and public health advocate, I understand the benefit of weight…
Opinion: First Opinion readers respond to essays on right to try lies, pharma execs, and more
First Opinion is STAT’s platform for interesting, illuminating, and maybe even provocative articles about the…
CDC slightly increases risk bird flu could cause a pandemic in latest assessment
The Centers for Disease Control and Prevention issued a new risk assessment of the H5N1…
Opinion: Noah Lyles collapse with Covid: How not to manage health at the Olympics
Noah Lyles, a 27-year-old from Gainesville, Florida, has had himself quite an Olympics. He won…
DO NOT PUBLISH: FDA rejects MDMA as a psychedelic treatment for PTSD
The Food and Drug Administration rejected MDMA as a treatment for post-traumatic stress disorder on…
Why Trump’s mifepristone comments were a gift to the Harris campaign
WASHINGTON — Former President Trump doesn’t want to talk much about abortion in his 2024 presidential…
FDA approves EpiPen alternative, a nasal spray for anaphylaxis
On Friday, the Food and Drug Administration approved the first needle-free treatment for adults and…
Morning Rounds: Another Ebola outbreak?
Want to stay on top of health news? Sign up to get our Morning Rounds newsletter in…
Why did Novo pull heart failure paperwork for Wegovy?
Hey, humans. Today, we talk about the decades-long pursuit to get MDMA approved as a…
STAT+: Pharmalittle: We’re reading about a California bill to restrain PBMs, a U.K. trade group scolding Novo, and more
And so, another working week will soon draw to a close. Not a moment too…
STAT+: A bespoke genetic therapy is helping Susannah. Can similar drugs be made at scale for other rare diseases?
Will it work? It was the question everyone around Susannah Rosen kept asking. Since infancy,…
MDMA therapy is facing an imminent FDA decision. Here’s what you need to know
A decades-long campaign to legalize MDMA as a mainstream medical treatment will reach a climax…
Opinion: Medicine needs fiction, especially now
The American medical system needs fiction because, as Albert Camus supposedly said, “Fiction is the…
.jpg)
STAT+: Medicare paid substantially more for J&J’s Stelara when it was covered under Part D than under Part B
A popular biologic medicine used to combat autoimmune diseases cost Medicare and its beneficiaries considerably…
STAT+: Judge rules against Chamber of Commerce in Medicare drug negotiation lawsuit
WASHINGTON — A federal judge on Thursday tossed out a U.S. Chamber of Commerce lawsuit…
STAT+: A U.K. trade group scolds Novo again — this time for remarks made by its CEO
Once again, Novo Nordisk has been admonished by a U.K. trade group for violating voluntary…
How experiencing famine in the womb may shape people’s health as adults
Hunger killed an estimated 4 million people in Ukraine between 1932 and 1933 — the…
STAT+: AI app claiming to diagnose STIs from penis pictures shut down after FTC scrutiny
The company that claimed its AI model could identify sexually transmitted infections from a single…
STAT+: Big Health gets FDA nod for its digital therapy for insomnia
Digital Therapeutics developer Big Health this week received Food and Drug Administration clearance for SleepioRx,…
As Covid deaths drop, heart disease and cancer remain leading causes of death
Since its emergence in 2020, Covid has jumbled the list of the 10 leading causes…
Listen: VC struggles, drug pricing negotiations, & Novo’s abrupt Wegovy decision
Why did Novo Nordisk pull its paperwork to expand the use of Wegovy for a…
Talkspace earnings, a framework for detecting AI hallucination, and trends in telehealth abortions
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology…